Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 310.00
Bid: 311.50
Ask: 318.00
Change: -1.50 (-0.48%)
Spread: 6.50 (2.087%)
Open: 310.00
High: 310.00
Low: 310.00
Prev. Close: 311.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block listing Interim Review

1 Jul 2019 10:01

RNS Number : 0052E
Oxford Biomedica PLC
01 July 2019
 

For Immediate Release

1 July 2019

 

OXFORD BIOMEDICA PLC

 

BLOCK LISTING RETURN

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

1 January 2019

To:

30 June 2019

Balance of unallotted securities under scheme(s) from previous return:

159,894

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

128,737

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

31,157

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Long Term Incentive Plan

Period of return:

From:

1 January 2019

To:

30 June 2019

Balance of unallotted securities under scheme(s) from previous return:

325,731

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

54,856

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

270,875

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Deferred Bonus Plan

Period of return:

From:

1 January 2019

To:

30 June 2019

Balance of unallotted securities under scheme(s) from previous return:

117,010

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

14,664

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

102,346

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Sharesave Scheme

Period of return:

From:

1 January 2019

To:

30 June 2019

Balance of unallotted securities under scheme(s) from previous return:

263,724

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

26,500

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

237,224

 

 

 

Name of contact:

Stuart Paynter

Telephone number of contact:

01865 783000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRUGUUUMUPBUBG
Date   Source Headline
31st Aug 20118:18 amRNSInterim Results- Replacement
31st Aug 20117:00 amRNSInterim Results
4th Aug 20114:35 pmRNSPrice Monitoring Extension
4th Aug 20117:00 amRNSInterim Data from ProSavin® Phase I/II Study
8th Jul 20119:12 amRNSHolding(s) in Company
28th Jun 20117:00 amRNSNotice of Results
7th Jun 20117:00 amRNSResearch Agreement with ImaginAb
26th May 20117:00 amRNSBlock Listing Six Monthly Return
24th May 20117:00 amRNSManagement and Board Changes
19th May 20114:40 pmRNSSecond Price Monitoring Extn
19th May 20114:35 pmRNSPrice Monitoring Extension
18th May 20117:00 amRNSInterim Management Statement
5th May 201112:54 pmRNSAnnual General Meeting and Board Changes
4th May 20117:00 amRNSPfizer License Extension
3rd May 20117:00 amRNSAnnouncement of Data in ProSavin Study
15th Apr 20111:04 pmRNSDirectors' Interest in Shares and Share Options
14th Apr 20114:40 pmRNSSecond Price Monitoring Extn
14th Apr 20114:35 pmRNSPrice Monitoring Extension
4th Apr 201110:28 amRNSAnnual Information Update
31st Mar 20117:12 amRNSAnnual Report and Accounts & AGM Notification
22nd Mar 20117:00 amRNSDirector/PDMR Shareholding
21st Mar 20117:01 amRNSDirectorate Change
21st Mar 20117:00 amRNSStarGen US IND Approval
2nd Mar 20117:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 DEC 2010
31st Jan 20114:40 pmRNSSecond Price Monitoring Extn
31st Jan 20114:35 pmRNSPrice Monitoring Extension
31st Jan 201112:20 pmRNSTotal Voting Rights Update
31st Jan 201112:19 pmRNSNotification of Major Interest in Shares
31st Jan 20117:00 amRNSAcquisition of Manufacturing Facility
20th Jan 20117:00 amRNSNotice of Preliminary Results
12th Jan 20118:20 amRNSHolding in Company
10th Jan 20118:47 amRNSDirectors' Interest in Shares
7th Jan 201111:30 amRNSResult of General Meeting
7th Jan 20117:00 amRNSResult of Open Offer
22nd Dec 20107:00 amRNSProSavin Phase I/II Update
14th Dec 20107:22 amRNSPublication of Prospectus
13th Dec 20104:50 pmRNSRe Proposed Fundraising
13th Dec 20107:47 amRNSProposed Fundraising
26th Nov 20107:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th Nov 20107:00 amRNSUS IND APPROVAL FOR RETINOSTAT
29th Oct 20107:00 amRNSOxford Biomedica PLC Interim Management Statement
26th Oct 20104:35 pmRNSPrice Monitoring Extension
26th Oct 20104:35 pmRNSPrice Monitoring Extension
14th Oct 20107:00 amRNSPublication in Clinical Cancer Research Journal
14th Oct 20107:00 amRNSChange of Adviser and Broker
22nd Sep 20107:00 amRNSTROVAX? SELECTED AS ONE OF TOP 10 ONCOLOGY PROJECT
15th Sep 201011:53 amRNSHolding(s) in Company
24th Aug 20107:00 amRNSHalf Yearly Report
18th Aug 201010:31 amRNSHolding(s) in Company
18th Aug 20107:00 amRNSEmergent Licensing Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.